English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/209432
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Characterization of a cholesteroNitrone (ISQ-201), a novel drug candidate for the treatment of ischemic stroke

AuthorsMartínez-Alonso, Emma; Escobar-Peso, Alejandro; Ayuso, Maria I.; Gonzalo-Gobernado, Rafael; Chioua, Mourad ; Montoya, Juan J.; Montaner, Joan; Fernández, Israel; Marco-Contelles, José ; Alcázar, Alberto
Keywordsantioxidant
brain ischemia
hydroxyl radical
ischemic stroke
neuroprotection
nitrones
steroids
reactive
Issue Date31-Mar-2020
PublisherMultidisciplinary Digital Publishing Institute
CitationAntioxidants 9(4): 291 (2020)
AbstractNitrones have a well-recognized capacity as spin-traps and are considered powerful free radical scavengers, which are two important issues in hypoxia-induced oxidative stress and cell death in brain ischemia. Consequently, nitrones have been proposed as therapeutic agents in acute ischemic stroke (AIS). In this paper, we update the biological and pharmacological characterization of ISQ-201, a previously identified cholesteronitrone hybrid with antioxidant and neuroprotective activity. This study characterizes ISQ-201 as a neuroprotective agent against the hypoxia-induced ischemic injury. Transitory four-vessel occlusion and middle cerebral artery occlusion (tMCAO) were used to induce cerebral ischemia. Functional outcomes were determined using neurofunctional tests. Infarct area, neuronal death, and apoptosis induction were evaluated. In addition, ISQ-201 reactivity towards free radicals was studied in a theoretical model. ISQ-201 significantly decreased the ischemia-induced neuronal death and apoptosis, in a dose-dependent manner, showing its therapeutic effect when administered up until 6 h after post-ischemic reperfusion onset, effects that remained after 3 months from the ischemic episode. Furthermore, ISQ-201 significantly reduced infarct volume, leading to recovery of the motor function in the tMCAO model. Finally, the theoretical study confirmed the reactivity of ISQ-201 towards hydroxyl radicals. The results reported here prompted us to suggest ISQ-201 as a promising candidate for the treatment of AIS.
Publisher version (URL)https://doi.org/10.3390/antiox9040291
URIhttp://hdl.handle.net/10261/209432
DOI10.3390/antiox9040291
E-ISSN2076-3921
Appears in Collections:(IQOG) Artículos
Files in This Item:
File Description SizeFormat 
cholesteroNitrone_drug_treatment_ischemic_stroke.pdf3,76 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.